Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy: long-term results of a phase 2 study.
|
Cancer
|
2010
|
2.48
|
2
|
Long-term outcomes of early-stage nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy alone.
|
Int J Radiat Oncol Biol Phys
|
2010
|
1.91
|
3
|
Prospective study of tailoring whole-body dual-modality [18F]fluorodeoxyglucose positron emission tomography/computed tomography with plasma Epstein-Barr virus DNA for detecting distant metastasis in endemic nasopharyngeal carcinoma at initial staging.
|
J Clin Oncol
|
2013
|
1.81
|
4
|
The role of concurrent chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma among endemic population: a meta-analysis of the phase III randomized trials.
|
BMC Cancer
|
2010
|
1.68
|
5
|
Results of a phase 2 study examining the effects of omitting elective neck irradiation to nodal levels IV and Vb in patients with N(0-1) nasopharyngeal carcinoma.
|
Int J Radiat Oncol Biol Phys
|
2012
|
1.68
|
6
|
Effect of total dose and fraction size on survival of patients with locally recurrent nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: a phase 2, single-center, randomized controlled trial.
|
Cancer
|
2014
|
1.44
|
7
|
Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy.
|
Eur J Cancer
|
2012
|
1.33
|
8
|
Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
|
Int J Radiat Oncol Biol Phys
|
2004
|
1.32
|
9
|
Treatment outcomes for different subgroups of nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy.
|
Chin J Cancer
|
2011
|
1.24
|
10
|
Postradiation nasopharyngeal necrosis in the patients with nasopharyngeal carcinoma.
|
Head Neck
|
2009
|
1.24
|
11
|
Long-term outcomes and prognostic factors of re-irradiation for locally recurrent nasopharyngeal carcinoma using intensity-modulated radiotherapy.
|
Clin Oncol (R Coll Radiol)
|
2011
|
1.21
|
12
|
Treatment outcomes after radiotherapy alone for patients with early-stage nasopharyngeal carcinoma.
|
Int J Radiat Oncol Biol Phys
|
2009
|
1.20
|
13
|
Phase III study comparing standard radiotherapy with or without weekly oxaliplatin in treatment of locoregionally advanced nasopharyngeal carcinoma: preliminary results.
|
J Clin Oncol
|
2005
|
1.17
|
14
|
Gambogic acid induces apoptosis in imatinib-resistant chronic myeloid leukemia cells via inducing proteasome inhibition and caspase-dependent Bcr-Abl downregulation.
|
Clin Cancer Res
|
2013
|
1.16
|
15
|
Different clinical significance of pre- and post-treatment plasma Epstein-Barr virus DNA load in nasopharyngeal carcinoma treated with radiotherapy.
|
Clin Oncol (R Coll Radiol)
|
2010
|
1.12
|
16
|
Outcome of fractionated stereotactic radiotherapy for 90 patients with locally persistent and recurrent nasopharyngeal carcinoma.
|
Int J Radiat Oncol Biol Phys
|
2007
|
1.11
|
17
|
Association of p73 G4C14-to-A4T14 polymorphism with human papillomavirus type 16 status in squamous cell carcinoma of the head and neck in non-Hispanic whites.
|
Cancer
|
2009
|
1.09
|
18
|
Intensity-modulated radiation therapy reduces radiation-induced trismus in patients with nasopharyngeal carcinoma: a prospective study with >5 years of follow-up.
|
Cancer
|
2011
|
1.09
|
19
|
Association of XRCC1 polymorphisms and risk of differentiated thyroid carcinoma: a case-control analysis.
|
Thyroid
|
2009
|
1.08
|
20
|
A randomized trial on addition of concurrent-adjuvant chemotherapy and/or accelerated fractionation for locally-advanced nasopharyngeal carcinoma.
|
Radiother Oncol
|
2011
|
1.04
|
21
|
Gambogic acid is a tissue-specific proteasome inhibitor in vitro and in vivo.
|
Cell Rep
|
2012
|
1.04
|
22
|
Exogenous low dose hydrogen peroxide increases hypoxia-inducible factor-1alpha protein expression and induces preconditioning protection against ischemia in primary cortical neurons.
|
Neurosci Lett
|
2008
|
1.01
|
23
|
Clinical findings and imaging features of 67 nasopharyngeal carcinoma patients with postradiation nasopharyngeal necrosis.
|
Chin J Cancer
|
2013
|
0.96
|
24
|
Human peritoneal mesothelial cell transformation into myofibroblasts in response to TGF-ß1 in vitro.
|
Int J Mol Med
|
2010
|
0.95
|
25
|
Radiation response genotype and risk of differentiated thyroid cancer: a case-control analysis.
|
Laryngoscope
|
2005
|
0.94
|
26
|
RET polymorphisms and haplotypes and risk of differentiated thyroid cancer.
|
Laryngoscope
|
2005
|
0.92
|
27
|
Optimal waveforms design for ultra-wideband impulse radio sensors.
|
Sensors (Basel)
|
2010
|
0.90
|
28
|
Enhanced NMDA receptor tyrosine phosphorylation and increased brain injury following neonatal hypoxia-ischemia in mice with neuronal Fyn overexpression.
|
Neurobiol Dis
|
2012
|
0.90
|
29
|
[Prophylactic irradiation at the level Ib for nasopharyngeal carcinoma: should that be a routine?].
|
Nan Fang Yi Ke Da Xue Xue Bao
|
2011
|
0.88
|
30
|
[Role of 18F-FDG PET/CT in diagnosis and staging of nasopharyngeal carcinoma].
|
Ai Zheng
|
2008
|
0.86
|
31
|
Associations of single nucleotide polymorphisms in miR-146a, miR-196a, miR-149 and miR-499 with colorectal cancer susceptibility.
|
Asian Pac J Cancer Prev
|
2014
|
0.85
|
32
|
Damage of nasal mucociliary movement after intensity-modulated radiation therapy of nasopharyngeal carcinoma.
|
Chin J Cancer
|
2010
|
0.83
|
33
|
Glutathione S-transferase polymorphisms and risk of differentiated thyroid carcinomas: a case-control analysis.
|
Arch Otolaryngol Head Neck Surg
|
2006
|
0.83
|
34
|
A prospective, randomized, multi-center trial to investigate Actovegin in prevention and treatment of acute oral mucositis caused by chemoradiotherapy for nasopharyngeal carcinoma.
|
Radiother Oncol
|
2010
|
0.83
|
35
|
[Short-term efficacy of endoscopy-guided debridement on radiation-related nasopharyngeal necrosis in 20 nasopharyngeal carcinoma patients after radiotherapy].
|
Ai Zheng
|
2008
|
0.80
|
36
|
[Evaluation of CT, MRI and PET-CT in detecting retropharyngeal lymph node metastasis in nasopharyngeal carcinoma].
|
Ai Zheng
|
2006
|
0.80
|
37
|
Adefovir dipivoxil modulates cytokine expression in Th1/Th2 cells in patients with chronic hepatitis B.
|
Mol Med Rep
|
2011
|
0.80
|
38
|
[Staging 915 cases of nasopharyngeal carcinoma after simple radical radiotherapy--checkout of Fuzhou staging system (1992)].
|
Ai Zheng
|
2005
|
0.80
|
39
|
X-ray repair cross-complementing group 1 (XRCC1) single-nucleotide polymorphisms and the risk of salivary gland carcinomas.
|
Cancer
|
2007
|
0.80
|
40
|
CT-guided needle biopsy through mandibular area for the diagnosis of nasopharyngeal carcinoma in the parapharyngeal space.
|
Chin J Cancer
|
2010
|
0.80
|
41
|
Temporal lobe injury after re-irradiation of locally recurrent nasopharyngeal carcinoma using intensity modulated radiotherapy: clinical characteristics and prognostic factors.
|
J Neurooncol
|
2014
|
0.80
|
42
|
[Clinical study in prophylactic use of chinese medicine to prevent chemoradiotherapy induced mucositis in nasopharyngeal carcinoma].
|
Ai Zheng
|
2003
|
0.79
|
43
|
Effectiveness of a Chinese hamster ovary cell derived hepatitis B vaccine in Chinese rural communities.
|
Vaccine
|
2011
|
0.79
|
44
|
Fas single nucleotide polymorphisms and risk of thyroid and salivary gland carcinomas: a case-control analysis.
|
Head Neck
|
2008
|
0.79
|
45
|
[Prognostic impact of plasma Epstein-Barr virus DNA concentration on distant metastasis in nasopharyngeal carcinoma].
|
Ai Zheng
|
2006
|
0.78
|
46
|
BCN nanotubes as highly sensitive torsional electromechanical transducers.
|
Nano Lett
|
2014
|
0.78
|
47
|
[The effect of overall treatment time on local control in nasopharyngeal carcinoma patients treated with intensity modulated radiation therapy].
|
Zhonghua Yi Xue Za Zhi
|
2011
|
0.78
|
48
|
[Retrospective analysis of 934 nasopharyngeal carcinoma patients treated with conventional external beam radiotherapy alone].
|
Zhonghua Zhong Liu Za Zhi
|
2005
|
0.78
|
49
|
[Phase II clinical trial of h-R3 combined radiotherapy for locoregionally advanced nasopharyngeal carcinoma].
|
Ai Zheng
|
2007
|
0.77
|
50
|
[Radiation-induced temporomandibular joint damage in nasopharyngeal carcinoma patients after intensity-modulated radiotherapy].
|
Ai Zheng
|
2007
|
0.77
|
51
|
Functional polymorphisms of matrix metalloproteinase-9 and survival in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy.
|
Med Oncol
|
2013
|
0.76
|
52
|
Genetic variations in radiation and chemotherapy drug action pathways and survival in locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy.
|
PLoS One
|
2013
|
0.76
|
53
|
Expression of matrix metalloproteinase-12 in aortic dissection.
|
BMC Cardiovasc Disord
|
2013
|
0.75
|
54
|
[Bioavailability of cadmium in seawater to Paralichthys olivaceus].
|
Ying Yong Sheng Tai Xue Bao
|
2005
|
0.75
|
55
|
[Contamination level of aflatoxin B1 in lotus seeds rapid screening by indirect competitive ELISA method].
|
Zhongguo Zhong Yao Za Zhi
|
2015
|
0.75
|
56
|
[Changes of hypoxia in primary lesion of nasopharyngeal carcinoma during the treatment course and the clinical value thereof].
|
Zhonghua Yi Xue Za Zhi
|
2007
|
0.75
|
57
|
[Clinical application of 99mTc-HL91 hypoxia imaging in nasopharyngeal carcinoma].
|
Ai Zheng
|
2006
|
0.75
|
58
|
Comprehensive treatment of squamous cell cancer of head and neck: Chinese expert consensus 2013.
|
Future Oncol
|
2014
|
0.75
|
59
|
[Correlation between the kinetics of plasma EBV DNA levels and clinical response during treatment in patients with nasopharyngeal carcinoma].
|
Ai Zheng
|
2002
|
0.75
|
60
|
[Intensity modulated radiation therapy for 49 patients with recurrent nasopharyngeal carcinoma].
|
Zhonghua Zhong Liu Za Zhi
|
2003
|
0.75
|
61
|
[Prognostic analysis of patients with cerebral glioma treated with radiotherapy].
|
Ai Zheng
|
2004
|
0.75
|
62
|
[Correlation of DNA ploidy in fresh tumor tissues to prognosis of nasopharyngeal carcinoma].
|
Ai Zheng
|
2007
|
0.75
|
63
|
[Radiologic criteria of MRI in diagnosing retropharyngeal lymph nodal metastasis of nasopharyngeal carcinoma].
|
Zhonghua Yi Xue Za Zhi
|
2006
|
0.75
|
64
|
A magnetoreception system constructed by a dysprosium metallofullerene and nitroxide radical.
|
Dalton Trans
|
2017
|
0.75
|
65
|
[To repair defects of facial skin and tissue with the axial flap].
|
Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
|
2015
|
0.75
|
66
|
[Design planning target volumes (PTVs) in intensity-modulated radiotherapy for nasopharyngeal carcinoma].
|
Ai Zheng
|
2007
|
0.75
|
67
|
[Staging 915 cases of nasopharyngeal carcinoma after simple radical radiotherapy (Part II)--Checkout of AJCC/UICC staging system (1997)].
|
Ai Zheng
|
2006
|
0.75
|
68
|
[Influence of patient setup error on planning risk volumes for nasopharyngeal carcinoma patients receiving intensity-modulated radiation therapy].
|
Ai Zheng
|
2008
|
0.75
|
69
|
[Weekly paclitaxel with concurrent intensity-modulated radiotherapy for nasopharyngeal carcinoma: outcomes of a tolerance trial].
|
Ai Zheng
|
2007
|
0.75
|
70
|
Molecular weight effects on the phase-change-enhanced temperature coefficient of resistance in carbon nanotube/poly(N-isopropylacrylamide) composites.
|
Nanotechnology
|
2015
|
0.75
|
71
|
Structure and Ca2+ regulation of frog photoreceptor guanylate cyclase, ROS-GC1.
|
Mol Cell Biochem
|
2003
|
0.75
|